B01AB10 • tinzaparin • Blood and blood forming organs | Antithrombotic agents | Heparin group
Tinzaparin is a low molecular weight heparin anticoagulant used for the prevention and treatment of deep vein thrombosis and pulmonary embolism. It works by inhibiting clotting factors, reducing the risk of blood clot formation.
The medication is administered as subcutaneous injections, as directed by a doctor. The dosage is adjusted based on the patient's weight and clinical condition.
Patients should be closely monitored to detect potential side effects, such as bleeding, injection site hematomas, or allergic reactions. It is important for patients to inform their doctor of any unusual symptoms.
Common side effects include bleeding, pain at the injection site, and elevated liver enzymes. In rare cases, severe reactions such as heparin-induced thrombocytopenia may occur. Patients should be informed of these risks before starting treatment.
Substance: tinzaparin
Date of last drug list: 01-10-2013
Commercial code: W42118002
Concentration: 20000u ANTIF. Xa / ml
Pharmaceutical form: injectible solution
Quantity: 2
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).